HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $55
Alto Neuroscience, Inc.
Alto Neuroscience, Inc. ANRO | 0.00 |
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Alto Neuroscience (NYSE:
ANRO) with a Buy and raises the price target from $50 to $55.